Drug Profile
AIDS associated myelopathy therapy - Genopia Biomedical
Latest Information Update: 24 Feb 2010
Price :
$50
*
At a glance
- Originator GENOPIA Biomedical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Spinal cord disorders
Most Recent Events
- 24 Feb 2010 Discontinued - Phase-II for Spinal cord disorders in Germany (unspecified route)
- 10 Aug 2004 Genopia's compound is available for licensing (http://www.genopia.de)
- 10 Aug 2004 Orphan Drug Status for AIDS associated myelopathy in USA